Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suprachoroidal MSC Implantation in Retinitis Pigmentosa
NCT05712148Phase 2Completed
- Sponsor
- Acıbadem University
- Start
- Oct 2019
- Primary completion
- Jan 2022
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of human umbilical cord mesenchymal stem cells in retinitis pigmentosa (RP), sponsored by Acıbadem University. Started Oct 2019; status: completed.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
retinitis pigmentosa (RP)
Beyond the preview
Go deeper on NCT05712148.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05712148.